CLAMICIN

This brand name is authorized in Nigeria.

Active ingredients

The drug CLAMICIN contains one active pharmaceutical ingredient (API):

1
UNII M6T05Z2B68 - LINCOMYCIN HYDROCHLORIDE
 

Lincomycin is an antibiotic produced by fermentation of Streptomyces lincolnensis. Lincomycin inhibits bacterial protein synthesis by binding to the 50S subunit of the bacterial ribosome.

 
Read more about Lincomycin

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
04-6793 Capsule Clamicin 500 Capsule CAP 500 mg 3 x 4's (in PVC/Aluminum foil blisters) Hard gelatin capsule 27/06/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
J01FF02 Lincomycin J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01F Macrolides, lincosamides and streptogramins → J01FF Lincosamides
Discover more medicines within J01FF02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database 04-6793

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.